ABU DHABI, 6 June / WAM / A delegation from the Abu Dhabi healthcare system led by His Excellency Sheikh Abdullah bin Mohammed Al Hamed, Chairman of the Abu Dhabi Department of Health, visits the United States this month to look for joint collaboration in the field of health care in general and innovation in life sciences in particular.
The visit will witness a number of meetings and the signing of agreements with a number of prominent partners to explore and activate aspects of collaboration in life sciences, real evidence, digital health, research and development, supply chains and other fields.
The visit of the delegation – which includes a number of representatives of government institutions and departments in the emirate – aims to develop sustainable mechanisms to proceed with the upgrading of the healthcare sector and the components of the leading health system in the Emirate of Abu To review Dhabi.
The delegation will witness the participation of representatives of 7 major entities in Abu Dhabi, including the Abu Dhabi Department of Health, Abu Dhabi Investment Office, Mubadala Healthcare, G42 Healthcare, Abu Dhabi Ports Group, ADQ Holding Company, Etihad Shipping and Pure Health .
The tour of the Abu Dhabi delegation begins from Washington, DC, with a visit to the Children’s Hospital, which includes the Sheikh Zayed Institute for the Development of Pediatric Surgery. He will then travel to Boston to visit a number of facilities specialized in the fields of healthcare and pharmaceutical industries to discuss prospects for collaboration with global partners. The visit looks forward to attracting innovative treatments and pioneering solutions to the UAE and the region, as well as the exchange of knowledge and expertise in the sector.
The delegation will conclude its visit to San Diego and participate in the World Conference of the Organization for Innovation in Biotechnology, which will be held from 13 to 16 June, where the delegation will explore the rapid development and steady growth that Abu Dhabi is having in the biotechnology sector.
His Excellency Sheikh Abdullah bin Muhammad Al Hamed said: “Societies around the world today realize more than ever the importance of mutual cooperation and unification of efforts in all sectors, as they face the repercussions of the Covid-19 pandemic. , the world has become fully convinced that the way to overcome any global health challenge is solidarity and working together, side by side, as we have seen the international community unite its efforts during the pandemic, solutions to the Under the wise leadership of the UAE, the UAE has presented a leading model of cooperation, tolerance and unity, which are core values embodied in our excellent efforts to promote health care locally and globally. . ” His Excellency Al Hamed added: “We look forward to meeting a group of partners in the United States with whom we have long-standing cooperation and partnership frameworks, as the two countries enjoy mutual bilateral relations, common values and cooperation that extend for decades, with the aim of achieving a significant social impact that benefits societies around the world. ” The two countries also have solid cultural ties which are translated by the multiple partnerships we continue to develop as we are proud of what the joint efforts have already achieved between the two countries and we look forward to achieving more achievements together. ”
The delegation looks forward to advancing research efforts supported by global partners to improve the resilience and sustainability of healthcare systems and provide high-quality care to patients around the world.
Abu Dhabi continues to work with global strategic partners to pave the way for a future driven by healthcare technology, innovation and artificial intelligence as part of the emirate’s strategy to improve the quality of healthcare outputs.
The health sector in Abu Dhabi includes many of the world’s leading healthcare providers, including Cleveland Clinic, Imperial College London, Mayo Clinic and Moorfields Eye Hospital. In addition, the emirate enjoys joint collaborative relationships with a number of leading international companies in the pharmaceutical and bio-industries, including Pfizer, AstraZeneca, Roche, Novartis, GlaxoSmithKline, MSD and Johnson & Johnson, aimed at enhancing local and global capabilities related with research and innovation in the life sciences Digital health and supply chains, as part of efforts to position Abu Dhabi as a leading destination in healthcare and life sciences.
Abu Dhabi was able to consolidate its position as an incubator for innovation in the life sciences, and achieved excellent results in dealing with the Covid-19 pandemic, as the world’s leading cities in response to the pandemic according to the deep knowledge group classification. In recent years, the emirate has become the focus of the world’s attention in dealing with emergencies and in launching innovative initiatives that focus on patients and meet their needs. The UAE has also consistently ranked among the top 3 countries in the world in the “Index of Resilience in Dealing with Covid 19” issued by the international agency “Bloomberg”.
The UAE was one of the first countries to participate in clinical trials of Covid-19 vaccines, which helped accelerate the pace of vaccine development and spread around the world, and the study led to the largest clinical trial on the Synopharm- vaccine seen, which included more. than 32,000 volunteers. COVID-19 “, which is a unified platform to support research and development efforts in the light of the pandemic, which has facilitated scientific discoveries to tackle the virus.
Abu Dhabi has produced more than 300,000 samples of the DNA extraction solution for Covid-19 locally, increased its capacity for “Corona” tests to more than 500,000 tests per day, and 27 vehicle-based examination and vaccination centers across the emirate supply.
In February 2021, the Abu Dhabi Health Department announced the support of the Emirate of Abu Dhabi for existing international efforts to conduct PCR investigations related to Covid-19, as the emirate has assigned modern laboratories to perform laboratory analyzes of samples received and collected from without. the UAE. In an initiative that is the first of its kind in the world, which confirms the leading position that Abu Dhabi enjoys at regional and global levels in the healthcare sector and the health services it provides at international quality levels.
Under the leadership of the Abu Dhabi Department of Health, Abu Dhabi launched the “Coalition of Hope” in the 2020 world, providing an advanced system for transporting, storing and distributing vaccines as it contributed to the spread from more than 260 million vaccines to more than 60 countries around the world. The capacity to store vaccines reaches 9 billion doses of vaccine. Abu Dhabi has strengthened ways of collaborating with Belgium as a leading global center in the world of pharmaceutical industries, aiming at a global air corridor for the distribution and transportation of vaccines and pharmaceuticals between Abu Dhabi and Brussels.
In addition, in line with the economic diversification strategy in the United Arab Emirates, the Department of Health Abu Dhabi currently provides support to more than 60 licensed start-ups, communicates with more than 300 start-ups around the world, and supports start-ups during the various stages of development , from developing ideas through developing plans and obtaining funding to expand into global markets.
In collaboration with Plug and Play, the Department of Health Abu Dhabi has launched an accelerator for beginners targeting solutions and companies from around the world. These efforts led to the creation of many new jobs and financial support worth more than $ 44 million, and the economic impact reached more than $ 55 million.
Abu Dhabi continues to attract and attract talents from around the world who want to live and work in the United Arab Emirates, where the healthcare sector in the emirate includes doctors and health workers from 98 countries around the world.
– Lead –